Deans' stroke musings: SwissNeuroRehab wins grant to build new treatment models for stroke, TBI

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, February 27, 2022

SwissNeuroRehab wins grant to build new treatment models for stroke, TBI

You'll want your stroke hospital to be closely following this. If your hospital doesn't have a research analyst whose only job is to follow and implement stroke research then you don't have a functioning stroke hospital. Which means your board of directors is incompetent.

SwissNeuroRehab wins grant to build new treatment models for stroke, TBI

SwissNeuroRehab, a collaborative effort led by Lausanne University Hospital to advance neurorehabilitation treatment across continuum of care, has won the Innosuisse Flagship award, according to a release.

The group will leverage more than 11.2 million CHF (12.2 million USD) toward creating therapeutic programs that safely and effectively combine the latest digital therapeutics and neurotechnology.

“With SwissNeuroRehab, we will set out to test novel digital therapeutic interventions for the treatment of neurological disease and neurological injury,” John Krakauer, MD, chief medical and scientific advisor at Swiss neurotechnology firm and project partner MindMaze, said in the release.

Along with MindMaze, SwissNeuroRehab is a collaboration among university hospitals, rehabilitation clinics, inpatient and outpatient providers, technical schools and other industry partners.

The project aims to create an effective and efficient model of neurorehabilitation focusing on stroke, traumatic brain injury and spinal cord injury, as well as a patient-centered model that will identify requirements needed to effectively treat physical and cognitive effects following stroke or injury.

Concurrent with therapeutic goals, the project will propose a reimbursement system and new educational curricula for health care professionals, patients and caregivers to implement in their respective disciplines.

Mortality, stroke rates after TAVR do not vary by age at 2 years
Lifestyle, diet modifications decrease stroke risk in middle-aged women

“The model will offer a long-term solution for acquired neurological injuries in the Swiss health system first, but its innovative ambition can develop solutions that can apply universally,” Andrea Serino, project coordinator of SwissNeuroRehab at Lausanne University Hospital, said in the release. “We look forward to piloting a model that will then generalize globally.”